Robotic surgery is now preferred by majority
of the gynecologist for the surgical treatment of patients with gynecologic
malignancies including endometrial, prolapsed or falling of pelvic organs,
ovarian cysts & masses, uterine fibroids, cervical, and ovarian cancer with
partial metastatic disease. Gynecologic surgery removes the cancerous cells
with a high level of care, leading to a better degree of surgical accuracy with
a lower possibility of risk and complications compared to conventional
procedures. Some of the other procedures include pelvic & aortic
lymphadenectomy, pelvic recurrences, radical trachelectomy, radical
hysterectomy, resection of diaphragm & liver metastases and isolated
recurrences of ovarian cancer.
The major advantages associated are smaller
incisions, faster recovery, fewer post-operative complications, decreased risk
of infection, early return to normal activities, less pain and shorter hospital
stay.
According to study, “Global
Gynecological Surgery Robots Market 2016-2025: Market Size, Share, Forecast and
Strategy” some of the major companies that are currently working in the
global gynecological surgery robots market are AVRA Surgical Robotics, Inc.,
Medrobotics Corporation, CAE Healthcare, NovaTract Surgical, Inc., Intuitive
Surgical, Omni Guide, Inc., Medtronic Inc., Titan Medical, Simbionix USA Corp.,
TransEnterix, Inc.
Based on components, global gynecological
surgery robotic market is segmented into a console, camera, robotic cart and
wristed instruments. In console, the surgeon makes an analysis or view from the
screen, manages the instruments & camera by finger graspers & foot
pedals. Camera allows for a three dimensional or 3D image of the pelvis with
image synchronizers & illuminators. Robotic cart includes three or four
interactive arms that hold apparatuses through trocars attached to the patient.
Based on disease type, the market is segmented
into endometrial cancer, ovarian cancer and cervical cancer. Based on
technology market is segmented into pelvic organ prolapsed repair, hysterectomy,
myomectomy (removal of fibroids), endometriosis, adnexal surgery, pediatric
gynecology, tubal anastomosis, tubal re-anastomosis, sacrocolpopexy (treatment
for pelvic organ prolapsed) & hysteropexy, interval cervical suture
placement, robotic assisted laparoscopic (removal of fibroids), and gynecologic
oncology. Hysterectomy is further sub-segmented into radical hysterectomy and
simple hysterectomy. Radical hysterectomy removes uterosacral ligaments,
parametria (bands of connective tissue in the pelvis), and upper vagina. Simple
hysterectomy involves removal of the uterus & cervix. Based on end-user,
market is segmented into hospitals & clinics, physicians’ offices,
ambulatory surgical centers (ASCs) and others.
The International Federation of Gynecology
& Obstetrics (FIGO) brings together professional or trained societies of
gynecologists from the global locations. It aims to promotes the safety of
women and raise standard of practice in gynecology.
The global gynecological surgery robots is driven
by increase in preference for minimally invasive surgery (MIS), followed by
increase in demand for procedures, increase in number for gynecological
disorders, enhance precision and need of eliminating any revisions with high
adoption of robotic-assisted techniques. Some of the other factors supporting
the adoption of MIS across the world are reduced hospital stay, recovery time,
and postoperative pain. In addition, one prime factor lead to the rise in
demand includes patient satisfaction that supports the manufacturers to extend
more advanced robotic equipment.
It is also expected that the global
gynecological surgery robot market to reach at US $2.9 billion, by 2025.
For more information, click on the
link below:
Contact Us:
Ken Research
Ankur
Gupta, Head Marketing & Communications
+91
9015378249
No comments:
Post a Comment